James C. Czirr, Executive Chairman at GALECTIN THERAPEUTICS INC (GALT), bought 1,000 shares at $6.90 ($7K) on 2013-11-15, disclosed to the SEC on 2013-11-18.
Open-market purchase of $7k GALT by Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |